Literature DB >> 28633544

Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectives.

Seema A Patil1, Raymond K Cross1.   

Abstract

INTRODUCTION: The development of penetrating Crohn's disease (CD) occurs in up to 50% of patients over the course of their lifetime. While the presentation of these complications, including free perforation, intra-abdominal abscess, and enteric fistula, are usually obvious, the management can require a nuanced approach, with distinct short and long-term approaches. Areas covered: This review discusses medical and surgical methods of treating these complications, including the role of percutaneous drainage of abscesses, the implications of a stricture associated with a fistula, and the efficacy of postoperative anti-TNF therapy in preventing recurrence after surgical treatment. Expert commentary: An approach to the management of these complications that begins with control of sepsis, including broad-spectrum antibiotics, bowel rest, and nutritional support is proposed. The next appropriate step is a diagnostic evaluation to determine the utility of medical versus surgical therapy, considering the presence of a stricture and prior immunosuppressive therapy. Postoperative anti-TNF therapy, a highly effective method to prevent recurrence, should be considered in many cases.

Entities:  

Keywords:  Abdominal abscess; Crohn’s disease; and infliximab; biological therapies; complications; fistula

Mesh:

Substances:

Year:  2017        PMID: 28633544     DOI: 10.1080/17474124.2017.1342536

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  5 in total

1.  Managing a Colonoscopic Perforation in a Patient with No Abdominal Wall.

Authors:  Jayan George; Michael Peirson; Samuel Birks; Paul Skinner
Journal:  Case Rep Surg       Date:  2018-07-10

2.  Parenteral Nutrition in Patients with Inflammatory Bowel Disease Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Jose M Comeche; Iris Comino; Cesare Altavilla; Jose Tuells; Ana Gutierrez-Hervas; Pablo Caballero
Journal:  Nutrients       Date:  2019-11-22       Impact factor: 5.717

3.  Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review.

Authors:  Yantian Cao; Qi Su; Bangjie Zhang; Fangfang Shen; Shaoshan Li
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

4.  A Validated Prognostic Model and Nomogram to Predict Early-Onset Complications Leading to Surgery in Patients With Crohn's Disease.

Authors:  Jiayin Yao; Yi Jiang; Jia Ke; Yi Lu; Jun Hu; Min Zhi
Journal:  Dis Colon Rectum       Date:  2021-06-01       Impact factor: 4.585

5.  Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn's Disease.

Authors:  Simon Kusan; Güzin Surat; Matthias Kelm; Friedrich Anger; Mia Kim; Christoph-Thomas Germer; Nicolas Schlegel; Sven Flemming
Journal:  J Clin Med       Date:  2022-07-26       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.